Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis

被引:49
作者
Kotler, DP
Shimada, T
Snow, G
Winson, G
Chen, W
Zhao, M
Inada, Y
Clayton, F
机构
[1] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Div Gastrointestinal Immunol, New York, NY 10025 USA
[2] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Med, Div Rheumatol, New York, NY 10025 USA
[3] Univ Utah, Salt Lake Vet Adm Hosp, Dept Pathol, Salt Lake City, UT USA
关键词
HIV RNA; antiretroviral therapy; intestine; mucous membranes; apoptosis;
D O I
10.1097/00002030-199806000-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Pathogen-negative diarrhea is common in HIV infection and has been associated with clinical symptoms, histopathology, HIV expression, CD4+ lymphocyte depletion, cytokine mRNA expression, and apoptosis of lamina propria mononuclear cells. Objectives and methods: To examine the short-term (7-day) effects of treatment with combination antiretroviral therapies upon gastrointestinal symptoms and rectal mucosa in 15 HIV-infected subjects. Results: Treatment was associated with significant decreases in the perception of abdominal bloating and cramps. Similar declines in RNA burden and rises in CD4+ lymphocyte counts were found in blood and mucosa. Treatment was also associated with a fall in the number of lamina propria mononuclear cells undergoing apoptosis by in situ labeling, a change that correlated with the change in mucosal viral burden. Conclusions: Peripheral blood and mucosal compartments are equally responsive to effective antiretroviral therapies. The detection of significant changes within 7 days of starting antiviral therapy implies that intestinal dysfunction may be a direct result of local HIV infection. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:597 / 604
页数:8
相关论文
共 56 条
[31]  
LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x
[32]  
LU SS, 1996, GASTROENTEROLOGY, V2, pA70
[33]   CYTOKINE GENE-EXPRESSION IN HIV-INFECTED INTESTINAL-MUCOSA [J].
MCGOWAN, I ;
RADFORDSMITH, G ;
JEWELL, DP .
AIDS, 1994, 8 (11) :1569-1575
[34]   PROGRAMMED DEATH OF T-CELLS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - NO CORRELATION WITH PROGRESSION TO DISEASE [J].
MEYAARD, L ;
OTTO, SA ;
KEAT, IPM ;
ROOS, MTL ;
MIEDEMA, F .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :982-988
[35]  
MUROCACHO CA, 1995, J IMMUNOL, V154, P5555
[36]  
NELSON JA, 1988, LANCET, V1, P259
[37]  
Pan ZG, 1996, AM J PATHOL, V149, P903
[38]   LYMPHOID ORGANS FUNCTION AS MAJOR RESERVOIRS FOR HUMAN-IMMUNODEFICIENCY-VIRUS [J].
PANTALEO, G ;
GRAZIOSI, C ;
BUTINI, L ;
PIZZO, PA ;
SCHNITTMAN, SM ;
KOTLER, DP ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9838-9842
[39]   HIV-INFECTION IS ACTIVE AND PROGRESSIVE IN LYMPHOID-TISSUE DURING THE CLINICALLY LATENT STAGE OF DISEASE [J].
PANTALEO, G ;
GRAZIOSI, C ;
DEMAREST, JF ;
BUTINI, L ;
MONTRONI, M ;
FOX, CH ;
ORENSTEIN, JM ;
KOTLER, DP ;
FAUCI, AS .
NATURE, 1993, 362 (6418) :355-358
[40]   Decay characteristics of HIV-1-infected compartments during combination therapy [J].
Perelson, AS ;
Essunger, P ;
Cao, YZ ;
Vesanen, M ;
Hurley, A ;
Saksela, K ;
Markowitz, M ;
Ho, DD .
NATURE, 1997, 387 (6629) :188-191